Gambling, Resorts & Casinos
Compare Stocks
4 / 10Stock Comparison
BRSL vs PENN vs CZR vs GENI
Revenue, margins, valuation, and 5-year total return — side by side.
Gambling, Resorts & Casinos
Gambling, Resorts & Casinos
Internet Content & Information
BRSL vs PENN vs CZR vs GENI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Gambling, Resorts & Casinos | Gambling, Resorts & Casinos | Gambling, Resorts & Casinos | Internet Content & Information |
| Market Cap | $2.35B | $2.24B | $5.66B | $1.17B |
| Revenue (TTM) | $2.51B | $6.96B | $11.56B | $669M |
| Net Income (TTM) | $147M | $-843M | $-485M | $-112M |
| Gross Margin | 47.1% | 30.6% | 43.9% | 22.9% |
| Operating Margin | 29.8% | -7.9% | 17.8% | -18.1% |
| Forward P/E | 14.7x | 23.0x | — | 52.4x |
| Total Debt | $4.25B | $8.38B | $26.34B | $30M |
| Cash & Equiv. | $1.45B | $687M | $887M | $281M |
BRSL vs PENN vs CZR vs GENI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 20 | May 26 | Return |
|---|---|---|---|
| Brightstar Lottery (BRSL) | 100 | 154.6 | +54.6% |
| PENN Entertainment,… (PENN) | 100 | 31.1 | -68.9% |
| Caesars Entertainme… (CZR) | 100 | 62.0 | -38.0% |
| Genius Sports Limit… (GENI) | 100 | 47.4 | -52.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BRSL vs PENN vs CZR vs GENI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BRSL carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 0.91, yield 30.8%
- Lower volatility, beta 0.91, current ratio 0.76x
- Lower P/E (14.7x vs 52.4x)
- 5.9% margin vs GENI's -16.7%
PENN is the #2 pick in this set and the best alternative if momentum is your priority.
- +6.7% vs GENI's -53.1%
CZR is the clearest fit if your priority is long-term compounding and defensive.
- 302.6% 10Y total return vs BRSL's 31.3%
- Beta 1.27, current ratio 0.80x
GENI is the clearest fit if your priority is growth exposure.
- Rev growth 31.0%, EPS growth -63.0%, 3Y rev CAGR 25.2%
- 31.0% revenue growth vs BRSL's -0.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.0% revenue growth vs BRSL's -0.0% | |
| Value | Lower P/E (14.7x vs 52.4x) | |
| Quality / Margins | 5.9% margin vs GENI's -16.7% | |
| Stability / Safety | Beta 0.91 vs GENI's 1.50 | |
| Dividends | 30.8% yield; 2-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +6.7% vs GENI's -53.1% | |
| Efficiency (ROA) | 1.6% ROA vs GENI's -11.1%, ROIC 11.7% vs -16.6% |
BRSL vs PENN vs CZR vs GENI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BRSL vs PENN vs CZR vs GENI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BRSL leads in 4 of 6 categories
PENN leads 0 • CZR leads 0 • GENI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BRSL leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CZR is the larger business by revenue, generating $11.6B annually — 17.3x GENI's $669M. BRSL is the more profitable business, keeping 5.9% of every revenue dollar as net income compared to GENI's -16.7%. On growth, GENI holds the edge at +37.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.5B | $7.0B | $11.6B | $669M |
| EBITDAEarnings before interest/tax | $1.1B | -$105M | $3.5B | -$50M |
| Net IncomeAfter-tax profit | $147M | -$843M | -$485M | -$112M |
| Free Cash FlowCash after capex | -$456M | -$169M | $538M | $37M |
| Gross MarginGross profit ÷ Revenue | +47.1% | +30.6% | +43.9% | +22.9% |
| Operating MarginEBIT ÷ Revenue | +29.8% | -7.9% | +17.8% | -18.1% |
| Net MarginNet income ÷ Revenue | +5.9% | -12.1% | -4.2% | -16.7% |
| FCF MarginFCF ÷ Revenue | -18.2% | -2.4% | +4.7% | +5.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.5% | +8.2% | +2.7% | +37.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -70.1% | +37.5% | +11.1% | +33.8% |
Valuation Metrics
BRSL leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, BRSL's 4.7x EV/EBITDA is more attractive than PENN's 13.8x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $2.3B | $2.2B | $5.7B | $1.2B |
| Enterprise ValueMkt cap + debt − cash | $5.2B | $9.9B | $31.1B | $924M |
| Trailing P/EPrice ÷ TTM EPS | -1269.00x | -2.88x | -11.48x | -10.83x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.65x | 22.95x | — | 52.42x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 4.67x | 13.81x | 8.90x | — |
| Price / SalesMarket cap ÷ Revenue | 0.94x | 0.32x | 0.49x | 1.75x |
| Price / BookPrice ÷ Book value/share | 1.57x | 1.33x | 1.57x | 1.68x |
| Price / FCFMarket cap ÷ FCF | — | — | 10.88x | 18.18x |
Profitability & Efficiency
BRSL leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
BRSL delivers a 9.2% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-35 for PENN. GENI carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to CZR's 7.15x. On the Piotroski fundamental quality scale (0–9), PENN scores 5/9 vs GENI's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.2% | -34.7% | -12.6% | -15.5% |
| ROA (TTM)Return on assets | +1.6% | -5.7% | -1.5% | -11.1% |
| ROICReturn on invested capital | +11.7% | +1.8% | +5.4% | -16.6% |
| ROCEReturn on capital employed | +12.9% | +2.0% | +7.0% | -15.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 5 | 3 |
| Debt / EquityFinancial leverage | 2.67x | 4.58x | 7.15x | 0.04x |
| Net DebtTotal debt minus cash | $2.8B | $7.7B | $25.5B | -$250M |
| Cash & Equiv.Liquid assets | $1.4B | $687M | $887M | $281M |
| Total DebtShort + long-term debt | $4.3B | $8.4B | $26.3B | $30M |
| Interest CoverageEBIT ÷ Interest expense | 3.66x | -1.02x | 0.90x | -136.57x |
Total Returns (Dividends Reinvested)
Evenly matched — CZR and GENI each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BRSL five years ago would be worth $10,703 today (with dividends reinvested), compared to $1,936 for PENN. Over the past 12 months, PENN leads with a +6.7% total return vs GENI's -53.1%. The 3-year compound annual growth rate (CAGR) favors GENI at 5.5% vs CZR's -15.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -15.6% | +12.9% | +17.9% | -55.8% |
| 1-Year ReturnPast 12 months | -2.4% | +6.7% | +2.5% | -53.1% |
| 3-Year ReturnCumulative with dividends | -33.8% | -35.3% | -38.6% | +17.4% |
| 5-Year ReturnCumulative with dividends | +7.0% | -80.6% | -73.7% | -74.6% |
| 10-Year ReturnCumulative with dividends | +31.3% | +11.9% | +302.6% | -52.4% |
| CAGR (3Y)Annualised 3-year return | -12.8% | -13.5% | -15.0% | +5.5% |
Risk & Volatility
Evenly matched — BRSL and CZR each lead in 1 of 2 comparable metrics.
Risk & Volatility
BRSL is the less volatile stock with a 0.91 beta — it tends to amplify market swings less than GENI's 1.50 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CZR currently trades 88.0% from its 52-week high vs GENI's 34.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.91x | 1.34x | 1.27x | 1.50x |
| 52-Week HighHighest price in past year | $18.57 | $20.61 | $31.58 | $13.73 |
| 52-Week LowLowest price in past year | $12.02 | $11.65 | $17.95 | $3.83 |
| % of 52W HighCurrent price vs 52-week peak | +68.3% | +81.4% | +88.0% | +34.7% |
| RSI (14)Momentum oscillator 0–100 | 47.1 | 55.1 | 54.5 | 45.3 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 4.4M | 4.6M | 5.6M |
Analyst Outlook
BRSL leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: BRSL as "Buy", PENN as "Buy", CZR as "Buy", GENI as "Buy". Consensus price targets imply 153.9% upside for GENI (target: $12) vs 10.0% for CZR (target: $31). BRSL is the only dividend payer here at 30.80% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $18.50 | $19.88 | $30.57 | $12.10 |
| # AnalystsCovering analysts | 6 | 47 | 30 | 19 |
| Dividend YieldAnnual dividend ÷ price | +30.8% | — | — | — |
| Dividend StreakConsecutive years of raises | 2 | — | 0 | 1 |
| Dividend / ShareAnnual DPS | $3.91 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +11.5% | +15.8% | +4.0% | 0.0% |
BRSL leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 2 categories are tied.
BRSL vs PENN vs CZR vs GENI: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is BRSL or PENN or CZR or GENI a better buy right now?
For growth investors, Genius Sports Limited (GENI) is the stronger pick with 31.
0% revenue growth year-over-year, versus -0. 0% for Brightstar Lottery (BRSL). Analysts rate Brightstar Lottery (BRSL) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — BRSL or PENN or CZR or GENI?
Over the past 5 years, Brightstar Lottery (BRSL) delivered a total return of +7.
0%, compared to -80. 6% for PENN Entertainment, Inc. (PENN). Over 10 years, the gap is even starker: CZR returned +302. 6% versus GENI's -52. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — BRSL or PENN or CZR or GENI?
By beta (market sensitivity over 5 years), Brightstar Lottery (BRSL) is the lower-risk stock at 0.
91β versus Genius Sports Limited's 1. 50β — meaning GENI is approximately 64% more volatile than BRSL relative to the S&P 500. On balance sheet safety, Genius Sports Limited (GENI) carries a lower debt/equity ratio of 4% versus 7% for Caesars Entertainment, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — BRSL or PENN or CZR or GENI?
By revenue growth (latest reported year), Genius Sports Limited (GENI) is pulling ahead at 31.
0% versus -0. 0% for Brightstar Lottery (BRSL). On earnings-per-share growth, the picture is similar: Genius Sports Limited grew EPS -63. 0% year-over-year, compared to -184. 4% for PENN Entertainment, Inc.. Over a 3-year CAGR, GENI leads at 25. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — BRSL or PENN or CZR or GENI?
Brightstar Lottery (BRSL) is the more profitable company, earning 2.
8% net margin versus -16. 7% for Genius Sports Limited — meaning it keeps 2. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BRSL leads at 35. 1% versus -15. 6% for GENI. At the gross margin level — before operating expenses — BRSL leads at 41. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is BRSL or PENN or CZR or GENI more undervalued right now?
On forward earnings alone, Brightstar Lottery (BRSL) trades at 14.
7x forward P/E versus 52. 4x for Genius Sports Limited — 37. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GENI: 153. 9% to $12. 10.
07Which pays a better dividend — BRSL or PENN or CZR or GENI?
In this comparison, BRSL (30.
8% yield) pays a dividend. PENN, CZR, GENI do not pay a meaningful dividend and should not be held primarily for income.
08Is BRSL or PENN or CZR or GENI better for a retirement portfolio?
For long-horizon retirement investors, Brightstar Lottery (BRSL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
91), 30. 8% yield). Genius Sports Limited (GENI) carries a higher beta of 1. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BRSL: +31. 3%, GENI: -52. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between BRSL and PENN and CZR and GENI?
These companies operate in different sectors (BRSL (Consumer Cyclical) and PENN (Consumer Cyclical) and CZR (Consumer Cyclical) and GENI (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BRSL is a small-cap income-oriented stock; PENN is a small-cap quality compounder stock; CZR is a small-cap quality compounder stock; GENI is a small-cap high-growth stock. BRSL pays a dividend while PENN, CZR, GENI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 18%
- Gross Margin > 13%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.